StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Reiterates Neutral on Rite Aid (RAD) Following 3Q Report
December 21, 2018 7:25 AM
JPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Next Articles
Rite Aid Successfully Completes Refinancing of Its Revolving Credit Facility
December 20, 2018 4:15 PM
Walgreens' cost-cut plans aim to save more than $1 billion annually
December 20, 2018 11:05 AM
Pre-Open Stock Movers 12/20: (AGEN) (TLRY) (PTE) Higher; (DBVT) (ADMA) (SPPI) Lower (more...)
December 20, 2018 9:29 AM
Rite Aid (RAD) Is Facing More Reimbursement Pressure - Goldman Sachs
December 20, 2018 7:25 AM
After-Hours Movers 12/19: (TLRY) (SB) (MLHR) Higher; (SPPI) (GTHX) (MNKD) (more...)
December 19, 2018 5:21 PM
Rite Aid (RAD) Tops Q3 EPS by 1c, Updates FY Guidance
December 19, 2018 4:18 PM
Rite Aid (RAD), McKesson (MCK) Announces Terms for Pharmaceutical Purchasing and Distribution
December 19, 2018 4:16 PM
Rite Aid Reports Fiscal 2019 Third Quarter Results
December 19, 2018 4:15 PM
Rite Aid and McKesson Agree to Key Terms for Pharmaceutical Purchasing and Distribution
December 19, 2018 4:15 PM
